By Mary J. Loftus
There’s an urgent need for vaccines effective against the world’s most challenging and emerging infectious diseases. To that end, Emory joins a team of forty-two universities and research institutions from thirteen countries that will work together through a new collaborative research program, Advanced Immunization Technologies. “A single laboratory cannot tackle modern vaccine science in isolation,” says coordinator Rino Rappuoli.
The partnership was launched last fall with funding from the European Union and other collaborating organizations. The mission is to develop technologies and a platform for innovation for the next generation of human vaccines by “exploiting the potential of the human immune system.” The Emory Vaccine Center is one of the largest groups of academic vaccine scientists in the world.